Gyroscope Therapeutics
Eunika Klimek is a finance professional with extensive experience in cash management and treasury services, currently serving as a Senior Cash Management & Treasury Services Specialist at Saint-Gobain since January 2024. Prior to this role, Eunika worked as a Financial Accounting Assistant at Gyroscope Therapeutics from January 2020 to January 2024 and held positions as a Finance Officer and in Finance/Administration at AxiomSL between August 2016 and January 2020. Eunika holds a Bachelor of Economics degree in Finance and Management in international companies from the State Higher Vocational School in Nowy Sacz, Poland, attended from 2007 to 2010.
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).